Schizophrenia Clinical Trial Pipeline Insights Featuring 55+ Companies | DelveInsight
October 09, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Schizophrenia Clinical Trial Pipeline Insights Featuring 55+ Companies | DelveInsight The rise in research and development activities in...
VEGFR-2 Antagonists Clinical Trial Pipeline Insights Featuring 25+ Companies | DelveInsight
October 08, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 08, 2024 (GLOBE NEWSWIRE) -- VEGFR-2 Antagonists Clinical Trial Pipeline Insights Featuring 25+ Companies | DelveInsight VEGFR2 (vascular endothelial growth factor receptor...
Innovative B7-H3 Inhibitors Set to Transform Cancer Treatment Landscape | DelveInsight
October 07, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Innovative B7-H3 Inhibitors Set to Transform Cancer Treatment Landscape | DelveInsight The market for B7-H3 inhibitors is expected to grow...
Global Inhalable Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight
October 03, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Global Inhalable Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight The increasing incidence of respiratory...
SERD Market is Predicted to Exhibit Remarkable Growth Owing to the Usage of Faslodex in Combination, Strong Performance of ORSERDU, and Speedy Progress of Other Oral SERDs, During the Study Period (2020–2034) | DelveInsight
October 02, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- SERD Market is Predicted to Exhibit Remarkable Growth Owing to the Usage of Faslodex in Combination, Strong Performance of ORSERDU, and Speedy...
Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
October 01, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
KRAS Inhibitors Market: New Treatments Are Set to Change Cancer Care | DelveInsight
September 30, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 30, 2024 (GLOBE NEWSWIRE) -- KRAS Inhibitors Market: New Treatments Are Set to Change Cancer Care | DelveInsight According to DelveInsight’s analysis, the growth of the KRAS...
Global Nicotine Replacement Therapy Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2030 | DelveInsight
September 26, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Global Nicotine Replacement Therapy Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2030 | DelveInsight The nicotine...
Sarcopenia Market Anticipates Impressive Growth Trajectory Across 7MM During the Study Period (2020–2034) | DelveInsight
September 25, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sarcopenia Market Anticipates Impressive Growth Trajectory Across 7MM During the Study Period (2020–2034) | DelveInsight The sarcopenia market...
Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
September 24, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...